Literature DB >> 1396324

Effects of selenium deficiency on thyroid hormone economy in rats.

J P Chanoine1, M Safran, A P Farwell, S Dubord, S Alex, S Stone, J R Arthur, L E Braverman, J L Leonard.   

Abstract

In selenium-deficient rats, peripheral T4 to T3 conversion is markedly decreased due to the loss of the selenoprotein, type I iodothyronine 5'-deiodinase (5'D-I). Despite the marked increase in circulating T4 that results from this loss of 5'D-I, serum T3 concentrations in selenium-deficient rats remain in the normal range. To determine the physiological mechanism(s) that maintains circulating T3 when peripheral T4 to T3 conversion is impaired, we examined the interrelationships between selenium intake and the metabolism of T3 and T4 in the rat. In euthyroid rats, selenium deficiency caused the expected loss of 5'D-I, with a 52% increase in serum T4, which paralleled an increase in the T4 biological half-life. Consistent with the prolonged t1/2 of T4, short term thyroidectomy (48 h) in selenium-deficient rats failed to decrease serum T4 concentrations to the levels observed in short term thyroidectomized, selenium-supplemented rats. Short term thyroidectomy also caused an expected 33% decrease in liver 5'D-I and a 44% increase in brain type II iodothyronine 5'-deiodinase (5'D-II) activities in selenium-supplemented rats. However, in selenium-deficient rats, short term thyroidectomy did not affect 5'D-I or 5'D-II activities. In contrast to the selenium-dependent changes in circulating T4 levels, little or no change in circulating T3 concentrations occurred. There was a 20% increase in the T3 half-life in selenium-deficient rats. The serum T3 sulfate concentration was increased, and T3 deiodination was reciprocally decreased in the selenium-deficient rats. These data suggest that increased T3 sulfate generation in selenium-deficient rats may lead to greater T3 availability through enterohepatic recycling of the iodothyronine and may explain why there are only minor changes in serum T3 concentrations in selenium-deficient rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396324     DOI: 10.1210/endo.131.4.1396324

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

Review 1.  Effects of selenium supplementation on the natural course of autoimmune thyroiditis: a short review.

Authors:  D Petricca; D Nacamulli; C Mian; F Mantero; E Cavedon; M E Girelli; C Betterle
Journal:  J Endocrinol Invest       Date:  2012-03-22       Impact factor: 4.256

2.  Relations between the selenium status and the low T3 syndrome after major trauma.

Authors:  M M Berger; T Lemarchand-Béraud; C Cavadini; R Chioléro
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

3.  Effects of selenium supplementation on thyroid hormone metabolism in phenylketonuria subjects on a phenylalanine restricted diet.

Authors:  M Calomme; J Vanderpas; B François; M Van Caillie-Bertrand; N Vanovervelt; C Van Hoorebeke; D Vanden Berghe
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

4.  The thyroid gland is a major source of circulating T3 in the rat.

Authors:  J P Chanoine; L E Braverman; A P Farwell; M Safran; S Alex; S Dubord; J L Leonard
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

5.  Selenium status and cardiovascular risk profile in healthy adult Saudi males.

Authors:  Eman M Alissa; Waqar H Ahmed; Nabeel Al-ama; Gordon A A Ferns
Journal:  Molecules       Date:  2008-12-31       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.